ALNOV:EPA
Novacyt SA
ā§Ļ.ā§Ēā§§âŦ
ā§Ļ.ā§Ļā§Ļ%
(ā§Ļ.ā§Ļā§Ļ) ā§§ āĻĻāĻŋ
ā§Ŧ āĻ¨āĻā§, ā§Ģ:ā§Šā§Ģ:ā§¨ā§§ PM GMT +ā§§ · EUR
search
āĻ¸āĻŦ āĻ¸āĻŋāĻŽā§āĻŦāĻ˛
| āĻ¸āĻŋāĻŽā§āĻŦāĻ˛ | āĻĻāĻžāĻŽ | āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ āĻāĻ°ā§āĻ¨ | % āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|
insights_autoALNOV-āĻāĻ° āĻāĻ¨ā§āĻ¯ āĻ¸ā§āĻ°āĻž āĻāĻ¨āĻ¸āĻžāĻāĻ āĻā§āĻ¨āĻžāĻ°ā§āĻ āĻāĻ°āĻž āĻšāĻā§āĻā§...
āĻā§āĻ˛ā§āĻ¨
ā§Ļ.ā§Ēā§§âŦ
āĻ¸āĻ°ā§āĻŦāĻžāĻ§āĻŋāĻ
ā§Ļ.ā§Ēā§§âŦ
āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨
ā§Ļ.ā§Ēā§ĻâŦ
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§¨.ā§ā§¨Â āĻā§
āĻ
ā§āĻ¯āĻžāĻāĻžāĻ°ā§āĻ āĻāĻ˛āĻŋāĻāĻŽ
ā§§.ā§Žā§ŽÂ āĻ˛āĻž
āĻāĻ˛āĻŋāĻāĻŽ
ā§§.ā§¨ā§Ļ āĻ˛āĻž
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦā§āĻā§āĻ āĻĻāĻžāĻŽ
ā§§.ā§Ļā§ĒâŦ
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨ āĻĻāĻžāĻŽ
ā§Ļ.ā§¨ā§¯âŦ
EPS
-ā§Ļ.ā§Šā§ŽâŦ
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ°
ā§.ā§¨ā§Ŧ āĻā§
āĻāĻ°ā§āĻŽā§āĻ¸āĻāĻā§āĻ¯āĻž
ā§¨ā§¨ā§Ž
āĻā§āĻ˛ā§āĻ¨
ā§Ļ.ā§Ēā§§âŦ
āĻ¸āĻ°ā§āĻŦāĻžāĻ§āĻŋāĻ
ā§Ļ.ā§Ēā§§âŦ
āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨
ā§Ļ.ā§Ēā§ĻâŦ
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§¨.ā§ā§¨Â āĻā§
āĻ
ā§āĻ¯āĻžāĻāĻžāĻ°ā§āĻ āĻāĻ˛āĻŋāĻāĻŽ
ā§§.ā§Žā§ŽÂ āĻ˛āĻž
āĻāĻ˛āĻŋāĻāĻŽ
ā§§.ā§¨ā§Ļ āĻ˛āĻž
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦā§āĻā§āĻ āĻĻāĻžāĻŽ
ā§§.ā§Ļā§ĒâŦ
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨ āĻĻāĻžāĻŽ
ā§Ļ.ā§¨ā§¯âŦ
EPS
-ā§Ļ.ā§Šā§ŽâŦ
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ°
ā§.ā§¨ā§Ŧ āĻā§
āĻāĻ°ā§āĻŽā§āĻ¸āĻāĻā§āĻ¯āĻž
ā§¨ā§¨ā§Ž
āĻāĻŦāĻ°ā§āĻ° āĻ¸ā§āĻā§āĻ°āĻŋ
āĻā§ā§āĻŦ āĻ¸ā§āĻ°ā§āĻ¸ āĻ āĻāĻŦāĻ°ā§āĻ° āĻĒāĻžāĻ°ā§āĻāĻ¨āĻžāĻ°āĻĻā§āĻ° āĻĨā§āĻā§
The Journal News | lohud.com
·
ā§Šā§¯ āĻŽāĻŋāĻ¨āĻŋāĻ āĻāĻā§
Stagwell Inc. (STGW) Reports Equity Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Reuters Connect
·
ā§Šā§Ļ āĻŽāĻŋāĻ¨āĻŋāĻ āĻāĻā§
Licensable picture: A trader reacts after the closing bell on the floor of the NYSE in New York
Investing.com
·
ā§¯ āĻŽāĻŋāĻ¨āĻŋāĻ āĻāĻā§
ZipRecruiter (NASDAQ:ZIP) cto Shimanovsky sells $140,877 in shares
The Motley Fool
·
ā§§ āĻāĻŖā§āĻāĻž āĻāĻā§
Midterms Are Over. Here's What History Says the S&P 500 Does Next.
āĻĒā§āĻ°ā§āĻĢāĻžāĻāĻ˛
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and VÊlizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Novacyt SA āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
āĻ¸āĻŋāĻāĻāĻĄā§āĻāĻŋāĻĄ āĻ
ā§āĻ¯āĻžāĻ˛āĻŽāĻ¨ā§āĻĄ
āĻāĻ°ā§āĻŽā§ā§¨ā§¨ā§Ž
āĻĒā§āĻ°āĻ¤āĻŋāĻˇā§āĻ āĻžāĻ° āĻ¤āĻžāĻ°āĻŋāĻā§Š āĻā§āĻ˛, ā§¨ā§Ļā§Ļā§Ŧ
āĻšā§āĻĄāĻā§ā§āĻžāĻ°ā§āĻāĻžāĻ°-
āĻ¸ā§āĻā§āĻāĻ°Health Care
āĻāĻ¨ā§āĻĄāĻžāĻ¸ā§āĻā§āĻ°āĻŋ-
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻnovacyt.com